Global Custom Market Research Reports Provider Company

phone

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway

  • Published Date: 14 May 2018
  • Number of Pages: 127
  • Category: Pharmaceuticals
  • Country: Norway
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Norway. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Norway. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Norway is a mature healthcare market, with a strong focus on healthcare spending. It spends approximately 10.5% of its GDP on healthcare. The value of the Norwegian pharmaceutical market increased from $2.18 billion in 2010 to $2.37 billion in 2017, at a Compound Annual Growth Rate (CAGR) of 1.2%. The market is forecast to grow to $2.53 billion in 2022. The medical device market increased from $1.31 billion in 2010 to $1.71 billion in 2017. The market is expected to grow at a CAGR of 4.9% from $1.79 billion in 2018 to $2.17 billion in 2022. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market. However, generic substitution and parallel imports pose as a barrier for the pharmaceutical companies.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Leo Pharma, Bayer and Vistin Pharma) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Philips Healthcare, Roche Diagnostics, Essilor and Photocure)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Norway
- Porters five forces analysis for pharmaceutical and medical devices market of Norway
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Norwegian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Norwegian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Norwegian healthcare market
Publisher Name : GlobalData

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List Of Tables

List of Tables
Table 1: OTC Market, Norway, Top Product Sales ($m), 2017 20
Table 2: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area ($m), 2017 21
Table 3: IVD Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017 41
Table 4: Ophthalmic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2015 42
Table 5: Orthopedic Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016 43
Table 6: Healthcare IT Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2016 44
Table 7: Cardiovascular Devices Market, Norway, Revenue ($m) and Market Share (%) of Major Companies, 2017 45
Table 8: Reimbursement Categories and Rates, Norway, 2015 78
Table 9: National Insurance Contribution Rates, Norway, 2016 79
Table 10: Pricing Procedures, Norway, 2015 82
Table 11: Market Authorization Fees, Norway, 2018 84
Table 12: Types of Import Authorizations for Clinical Studies, Norway, 2017 94
Table 13: Patent Fees, Norway, 2017 95
Table 14: Trademark Fees, Norway, 2017 97
Table 15: Clinical Trial Regulation, Norway, 2017 98
Table 16: Advertising Regulations, Norway, 2017 99
Table 17: Labeling and Packaging Regulations, Norway, 2017 101
Table 18: Nordic Package 101
Table 19: Trade Fairs, Norway, 2018-2019 113

List Of Figures

List of Figures
Figure 1: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017 8
Figure 2: Medical Device Market, Norway, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, Norway, 2017 14
Figure 4: Pharmaceutical Market, Norway, Revenue ($bn), 2010-2017 16
Figure 5: Pharmaceutical Market, Norway, Revenue Forecast ($bn), 2018-2022 16
Figure 6: Pharmaceutical Exports ($bn), Norway, 2010-2016 17
Figure 7: Top Export Partners, Norway, 2016 17
Figure 8: Pharmaceutical Imports ($bn), Norway, 2010-2016 18
Figure 9: Top Import Partners, Norway, 2016 18
Figure 10: Pharmaceutical Value Chain, Norway, 2017 19
Figure 11: Pharmaceutical Market, Norway, Pharmaceutical Sales by Therapeutic Area($m), 2017 21
Figure 12: Pharmaceutical Market, Norway, Major Players 23
Figure 13: Medical Device Market, Norway, Revenue ($bn), 2010-2017 39
Figure 14: Medical Device Market, Norway, Revenue Forecast ($bn), 2018-2022 39
Figure 15: Medical Device Market, Norway, Revenue by Segment ($m), 2017 40
Figure 16: IVD Devices Market, Norway, Revenue ($m), 2010-2017 41
Figure 17: IVD Devices Market, Norway, Market Share of Major Players (%), 2017 41
Figure 18: Ophthalmic Devices Market, Norway, Revenue ($m), 2010-2017 42
Figure 19: Ophthalmic Devices Market, Norway, Market Share of Major Players (%), 2015 42
Figure 20: Orthopedic Devices Market, Norway, Revenue ($m), 2010-2017 43
Figure 21: Orthopedic Devices Market, Norway, Market Share of Major Players (%), 2016 43
Figure 22: Healthcare IT Market, Norway, Revenue ($m), 2010-2017 44
Figure 23: Healthcare IT Market, Norway, Market Share of Major Players (%), 2016 44
Figure 24: Cardiovascular Devices Market, Norway, Revenue ($m), 2010-2017 45
Figure 25: Cardiovascular Devices Market, Norway, Market Share of Major Companies (%), 2017 45
Figure 26: Diagnostic Market, Norway, Revenue ($m), 2010-2017 46
Figure 27: Diagnostic Market, Norway, Revenue ($m), 2018-2022 46
Figure 28: Medical Device Market, Norway, Revenue ($bn) of Major Companies, 2016 48
Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Norway, 2017-2018 68
Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Norway, 2017-2018 68
Figure 31: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Norway, 2017-2018 68
Figure 32: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Value ($m), 2017-2018 69
Figure 33: Pharmaceutical Market, Norway, Top Five Therapy Areas by Deal Number, 2017-2018 69
Figure 34: Pharmaceutical Market, Norway, M&A Deals by Therapy Area, 2017-2018 69
Figure 35: Pharmaceutical Market, Norway, Venture Financing Deals by Therapy Area, 2017-2018 69
Figure 36: Medical Device Market Deals by Deal Value ($m), Norway, 2017-2018 70
Figure 37: Medical Device Market Deals by Deal Count, Norway, 2017-2018 70
Figure 38: Medical Device Market Deals Share by Deal Count, Norway, 2017-2018 70
Figure 39: Medical Device Market Deals Share (by deal value), Norway, 2017-2018 70
Figure 40: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018 71
Figure 41: Medical Devices, Norway, Top Therapy Area by Deal Number, 2017-2018 71
Figure 42: Medical Devices, Norway, M&A Deals by Therapy Area, 2017-2018 71
Figure 43: Medical Devices, Norway, Venture Financing Deals by Therapy Area, 2017-2018 71
Figure 44: Medical Devices, Norway, Private Equity Deals by Therapy Area, 2017-2018 71
Figure 45: Organization of the Health System, Norway, 2016 76
Figure 46: Decision Making Process, Norway, 2015 77
Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Norway, 2010-2016 81
Figure 48: Annual Rate of Change (%), Health Price Index, Norway, 2010-2017 81
Figure 49: Norway Medicines Agency, Organization Chart, 2017 83
Figure 50: National Procedure, Norway, 2017 85
Figure 51: Centralized Procedure, Norway, 2017 86
Figure 52: Decentralized Procedure, Norway, 2017 87
Figure 53: Medical Device Market Deals Share (by deal value), Norway, 2017-2018 70
Figure 54: Medical Device, Norway, Top Therapy Area by Deal Value, 2017-2018 71
Figure 55: Mutual Recognition Procedure, Norway, 2017 88
Figure 56: Conformity Assessment of Class I Medical Devices, EU, 2017 90
Figure 57: Conformity Assessment of Class IIa Medical Devices, EU, 2017 91
Figure 58: Conformity Assessment of Class IIb Medical Devices, EU, 2017 92
Figure 59: Conformity Assessment of Class III Medical Devices, EU, 2017 93
Figure 60: European Patent Approval Process, EU, 2017 96
Figure 61: Number of Hospitals, Norway,2010-2017 104
Figure 62: Diagnostic Equipment (per million population), Norway,2010-2017 104
Figure 63: Hospital Beds (per 1,000 population), Norway, 2010-2017 105
Figure 64: Curative Care Hospital Beds (per 1,000 population), Norway, 2010-2017 105
Figure 65: Psychiatric Hospital Beds (per 1,000 population), Norway, 2010-2017 105
Figure 66: Life Expectancy (in years), Norway, 2010-2017 106
Figure 67: Immunization Rate (%), Norway, 2010-2017 106
Figure 68: PM2.5 (g per m3), Norway, 2010-2017 107
Figure 69: CO2 Emissions (metric tons per capita), Norway, 2010-2017 107
Figure 70: Physicians (per 1,000 population), Norway, 2010-2017 108
Figure 71: Nurses (per 1,000 population), Norway, 2010-2017 108
Figure 72: Dentists, (per 1,000 population), Norway, 2010-2017 108
Figure 73: Pharmacists, (per 1,000 population), Norway, 2010-2017 108
Figure 74: Major Causes of Mortality (Number of Deaths, 000), Norway, 2015 109
Figure 75: Major Causes of Male Mortality (Number of Deaths, 000), Norway, 2015 109
Figure 76: Major Causes of Female Mortality (Number of Deaths, 000), Norway, 2015 109
Figure 77: Disability-Adjusted Life Years by Major Disease (000), Norway, 2015 109
Figure 78: Healthcare Expenditure as Percentage of GDP (%), Norway, 2010-2017 110
Figure 79: Public-Private Share (%), Norway, 2010-2017 110
Figure 80: Major Components of Healthcare Expenditure(%), Norway, 2016 111
Figure 81: Spending in Pharmaceutical and Healthcare R&D ($m), Norway, 2010-2015 111
Figure 82: Opportunities & Challenges, Norway 115

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Norway . The report is an essential

View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand . The report is

View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium . The report is an essential

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports